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Antimicrobial activities were detected in the haemolymph of the spider Acanthoscurrria rondoniae. A
novel antifungal peptide, rondonin, was puriﬁed by reverse phase high performance liquid chromato-
graphy (RP-HPLC). Rondonin has an amino acid sequence of IIIQYEGHKH and a molecular mass of
1236.776 Da. This peptide has identity to a C-terminal fragment of the ‘‘d’’ subunit of haemocyanin
from the spiders Eurypelma californicum and Acanthoscurria gomesiana. A synthetic peptide mimicking
rondonin had identical characteristics to those of the isolated material, conﬁrming its sequence. The
synthetic peptide was active only against fungus. These data led us to conclude that the antifungal
activity detected in the plasma of these spiders is the result of enzymatic processing of a protein that
delivers oxygen in the haemolymph of many chelicerate. Several studies have suggested that
haemocyanins are involved in the arthropod immune system, and the activity of this haemocyanin
fragment reinforces this idea.
& 2012 Elsevier B.V. Open access under CC BY-NC-ND license.1. Introduction
Invertebrate animals can be found in almost every habitat in
the world. Because many invertebrates live in environments in
which microorganisms thrive, their widespread distribution and
survival are primarily due to successful defences that efﬁciently
recognise and combat potentially harmful microorganisms [37].
Invertebrates only possess innate immunity, which is considered
to be an ancient defence mechanism [16].
One characteristic of innate immunity is the production of
antimicrobial substances, which are often peptides or polypep-
tides [12]. Several of these antimicrobial peptides (AMPs) have
been recognised as important components of the nonspeciﬁc host
defence or innate immune system in a variety of organisms and
have been isolated and characterised from plants and animals,
including insects, molluscs, crustaceans, amphibians, birds, ﬁsh,
mammals, and humans [2,17,3,11]. Several antimicrobial peptides
were isolated from the venom and haemolymph of venomous
arthropods such as scorpions and spiders [22]. The haemolymph
of invertebrates are the main source of antimicrobial peptides
[14]. The ﬁrst biochemical study of an antimicrobial peptide in
arachnids demonstrated the presence of an antibacterial peptidenologia Aplicada, CAT/CEPID,
-900 S~ao Paulo – SP, Brazil.
v.br (P.I. Silva Jr.).
Y-NC-ND license.in the haemolymph of the scorpion species Leiurus quinquestriatus
[5] and Androctonus australis [8]. Gomesin was the ﬁrst antimi-
crobial peptide isolated from spider blood cells [34]. Other
antimicrobial peptides were found in the plasma of shrimp [6],
freshwater crayﬁsh [24], the plasma of the tarantula spider
Acanthoscurria gomesiana, named theraphosinin [34], and crude
haemolymph of Agelena labyrinthica [46]. These peptides are
typically relatively short, positively charged (cationic), and
amphiphilic [19,40] and generally interact with the outer mem-
branes of microorganisms due to their negative charge [20].
Compared to cationic AMPs, much less is known about how
anionic AMPs work [39,36,13].
While most AMPs are derived from a biologically inactive
proprotein that is processed into an active state, some AMPs are
derived from larger, functional proteins, such as haemoglobin
[10,23,25,41] and haemocyanin [6,24]. Arthropod haemocyanins
are composed of heterogeneous subunits in the 75-kDa range that
combine to form either a regular cubic single hexamer (16) or
multiple hexamers (2–86) depending upon the species and
physiological conditions [29]. The haemocyanin of the North
American tarantula Eurypelma californicum is a native 24-mer
protein complex consisting of two identical dodecamers with an
estimated total molecular mass of approximately 1800 kDa
[33,26,27,29]. Formation of the 24-mer complex requires the
aggregation of seven different subunits in a constant stoichio-
metric amount with four copies of each of the subunits a, d, e, f,
and g and two copies of subunits b and c [28,29]. Since
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A. gomesiana and Acanthoscurria rondoniae which belongs to the
same genera, we choose this species to look for the presence of
these peptides. So, in the present study, we report the ﬁrst
isolation and characterisation of an antifungal fragment of hae-
mocyanin from arachnids.2. Experimental procedures
2.1. Microorganisms
Fungal and bacterial strains were obtained from various
sources. Escherichia coli SBS363 and Micrococcus luteus A270 were
from the Pasteur Institut, Paris; Candida albicans (MDM8) was
from the Department of Microbiology from the University of S~ao
Paulo, Brazil; and E. coli ATCC 25922, Pseudomonas aeruginosa
ATCC 27853 (Strain Boston 41501), Staphylococcus aureus ATCC
29213 and S. epidermides ATCC 12228 were from the American
Type Culture Collection (ATCC). The following human clinical
yeast isolates, which can be agents of candidiasis disease,
obtained from the Oswaldo Cruz Institute, Brazil, were also used:
Trichosporon sp. IOC 4569, Candida krusei IOC 4559, C. glabrata IOC
4565, C. albicans IOC 4558, C. parapsilosis IOC 4564, C. tropicalis
IOC 4560 and C. guilliermondii IOC 4557. The ﬁlamentous fungi
Aspergilus niger, Cladosporium sp. and Penicilium expansum and
Beauveria bassiana, an entomopathogenic fungus, were isolated
from a mummiﬁed spider.
2.2. Spider blood
The spiders (Acanthoscurria rondoniae, a tarantula of the
Theraphosidae family) were kept alive in the biotherium of the
Special Laboratory of Toxinology Applied of the Institute Butantan
(S~ao Paulo, Brazil) (Fig. 1). These animals were collected under
Licence Permanent Zoological Material no. 11024-3-IBAMA and
Special Authorisation for Access to Genetic Patrimony no. 001/
2008. The haemolymph (approximately 10 mL) from animals of
either sex at different stages of development was collected by
cardiac puncture with an apyrogenic syringe. To avoid haemocyte
degranulation and coagulation, the haemolymph was collected in
the presence of sodium citrate buffer (0.14 M NaCl, 0.1 M glucose,
30 mM trisodium citrate, 26 mM citric acid, 10 mM EDTA, pH 4.6
(2:1, v/v)) [38]. The plasma was separated, and the blood cells
were removed by centrifugation at 800g for 10 min at 4 1C.
2.3. Antimicrobial activity assays
During the puriﬁcation procedure, the antimicrobial activities
of the samples were monitored by a liquid growth inhibitionFig. 1. Specimen of the spider Acanthoscurria rondoniae (Theraphosidae,
Mygalomorphae).assay using the Gram-negative bacteria Escherichia coli SBS363,
Gram-positive bacteria Micrococcus luteus A270 that were cul-
tured in poor broth nutrient medium (PB: 1.0 g peptone in 100 ml
of water containing 86 mM NaCl at pH 7.4; 217 mOsM), whereas
yeast strain Candida albicansMDM8 was cultured in poor dextrose
broth (1/2 PDB:1.2 g potato dextrose in 100 ml of H2O at pH 5.0;
79 mOsM). Determination of antimicrobial peptide was per-
formed using 5-fold microtiter broth dilution assay in 96-well
sterile plates at a ﬁnal volume of 100 mL. Mid-log phase culture
were diluted to a ﬁnal concentration of 1105 colony forming
units/mL. Dried fractions were dissolved in 200 mL of water
ultrapure and 20 mL applied into each well and added to 80 mL
of the bacterium/yeast dilution. The fractions were tested in
triplicate. The microtiter plates were incubated for 18 h at
30 1C; growth inhibition was determined by measuring absor-
bance at 595 nm.
2.4. Puriﬁcation of rondonin from plasma
For puriﬁcation of antimicrobial peptides, the plasma was
homogenised and then triﬂuoracetic acid was added to a ﬁnal
concentration of 0.05%. The sample was agitated on ice for 30 min
and centrifuged at 16,000g at 4 1C. The acidic supernatant was
loaded onto classic Sep-Pak C18 cartridges equilibrated in acid-
iﬁed water (TFA 0.05%). After washing with acidiﬁed water, three
stepwise elutions were successively performed with 5%, 40% and
80% acetonitrile (ACN/TFA 0.05%). The 40% Sep-Pak fraction was
concentrated in a vacuum centrifuge and reconstituted in Milli-Q
water (MilliporeTM) and directly subjected to C18 reverse-phase
on a semi-preparative Jupiter C18 column equilibrated at room
temperature with 0.05% triﬂuoracetic acid in water. The sample was
puriﬁed using acetonitrile/water/0.05% triﬂuoracetic acid gradients of
2–60% acetonitrile in 60min at a ﬂow rate 1.5 mL/min. Ultraviolet
absorbance was monitored at 225 nm. The eluted peaks fractions
were collected by hand and were vacuum dried (Speed-Vac Savant)
and used for assay of antimicrobial activity and determination of
amino acid sequence.
2.5. Rondonin mass analysis by MALDI-TOF and LC/MS
Brieﬂy, 0.35 mL of sample in Milli-Q water was mixed with
0.35 mL of saturated matrix a-cyano-4-hydroxycinnamic acid
solution deposited onto the sample slide and dried on the bench.
The analysis was performed with the spectrometer operating in
positive mode, which detects positively charged ions. To deter-
mine the amino acid sequence of rondonin, the doubly charged
ions were subjected to ‘‘de novo’’ sequencing in a Q-TOF Ultima
API (Micromass) spectrometer operating in positive ionisation
mode. The spectrum was analysed, and the ‘‘y’’ and ‘‘b’’ fragments
were used to elucidate the primary structure of the molecule.
2.6. Peptide synthesis of rondonin
Synthetic rondonin was synthesised by solid phase peptide
synthesis using the Fmoc procedure [1]. The peptide was puriﬁed
by reverse phase (Shim-pack Prep-ODS, 5 m, 20 mm250 mm
Shimadzu Co.) semi-preparative HPLC, and the purity and identity
of the peptide were conﬁrmed by MALDI-TOF mass spectrometry
and analytical HPLC using the conditions described above.
2.7. Minimal inhibitory concentration (MIC) of rondonin
The minimal inhibitory concentration was determined using the
synthetic peptide against the Gram-negative bacterial strains, the
Gram-positive bacterial strains, the fungal strains and the yeast
strains, as described above (experimental procedures 2.1 and 2.3).
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concentration of 670 mM. Determination of minimal inhibitory
concentrations (MICs) for rondonin was performed using a 5-fold
microtiter broth dilution assay of stock solution (670 mM) and serial
dilution in 96-well sterile plates at a ﬁnal volume of 100 mL where
20 mL of stock solution was applied into each well at serial dilution
2-fold microtiter broth dilution and added to 80 mL of the bacter-
ium/yeast dilution. Microbial growth was measured by monitoring
the increase in OD at 595 nm after incubation at 30 1C for 18 h
(modiﬁed [8]). The rondonin was tested in duplicate. The MIC is
deﬁned as the minimal concentration of peptide that caused 100%
growth inhibitions [47].
2.8. Antifungal assay of rondonin
The antifungal assay was performed using a 5-fold microtiter
broth dilution assay and serial dilution in 96-well sterile plates at
a ﬁnal volume of 100 mL where 20 mL of stock solution (670 mM)
was applied into each well at serial dilution 2-fold microtiter
broth dilution and added to 80 mL of the yeast dilution. The
inhibition growth curve of rondonin was determined by incubat-
ing twice the concentration of the MIC (67 mM) of rondonin with
C. albicans MDM8 at 30 1C for various amounts of time (0, 10 min,
1 h, 3 h, 5 h, 8 h, 10 h, 12 h, 18 h, and 24 h) and counting the
number of conidia present; the viability of the yeast was veriﬁed
by incubating the colonies on a nutrient agar plate (1.5%). The
rondonin was tested in triplicate.
2.9. Haemolytic assay to determine rondonin toxicity
Human erythrocytes from a healthy donor were collected in
0.15 M citrate buffer, pH 7.4, and washed three times by cen-
trifugation (700g, 10 mins, 4 1C) with 0.15 M phosphate-buffered
saline (PBS), pH 7.4. After the ﬁnal centrifugation, the erythro-
cytes were suspended in PBS, pH 7.4. Aliquots of 50 mL containing
rondonin at concentrations ranging from 0.2 to 134 mM were
added to 50 ml of a 3% suspension of erythrocytes in the wells ofTable 1
Antimicrobial activity spectrum of synthetic rondonin compared to gomesin. The m
by liquid growth inhibition. MICs are expressed as the (a) and (b) interval of concentrat





Staphylococcus aureus ATCC 29213
Staphylococcus epidermides ATCC 12228
Gram-negative bacteria
Escherichia coli SBS363
Escherichia coli ATCC 25922
Pseudomonas aeruginosa ATCC 27853 (Strain Boston 41501)
Fungi
Beauveria bassiana
Trichosporon sp IOC 4569 1.1
Yeasts
Candida albicans MDM8 16.75
Candida krusei IOC 4559 16.75
Candida glabrata IOC 4565 8.37
Candida albicans IOC 4558 8.37
Candida parapsilosis IOC 4564 16.75
Candida tropicalis IOC 4560 8.75
Candida guilliermondii IOC 4557 16.75
The highest concentration tested was 67 mM. ND, activity not detected in the range of
a Silva et al. [35].
b Yamane [44].U-shaped bottom plates and incubated for 3 h at 37 1C. The
supernatant was ﬁrst collected and haemolysis was determined
by measuring the absorbance at 414 nm of each well in a Victor3
(1420 Multilabel Counter/Victor3, Perkin Elmer). The haemolysis
percentage was expressed in relation to a 100% lysis control
(erythrocytes incubated with 0.1% triton X-100); PBS was used as
a negative control. The rondonin was tested in triplicate.3. Results
3.1. Antimicrobial activity of rondonin measured by liquid growth
inhibition
Antimicrobial activity of synthetic rondonin was screened
using 3 species of Gram-positive bacteria, 3 species of Gram-
negative bacteria, 7 species of yeast and 2 species of fungi.
Rondonin was tested against these organisms at concentrations
ranging from 0.1 to 67 mM and demonstrated antimicrobial
activity against all 7 species of yeast and one species of ﬁlamen-
tous fungus (Table 1).
3.2. Puriﬁcation of rondonin from plasma
The plasma of the spider A. rondoniae from the Theraphosidae
family was collected (10 mL) and dissolved in acidiﬁed Milli-Q
water as previously described. The supernatant obtained by
centrifugation was applied to a Sep-Pak C18 column and sub-
jected to three successive extractions of increasing concentrations
of acetonitrile (5%, 40% and 80% ACN) to pre-purify antimicrobial
peptides. The material eluted at 40% ACN was subjected to
fractionation by RP-HPLC, which resulted in fractions with anti-
microbial activity (Fig. 2). All fractions were analysed in the liquid
growth inhibition assay using M. luteus, E. coli, and C. albicans. We
found six fractions that showed antimicrobial activity only
against C. albicans: 2, 3, 7, 11, 12, and 13. Only the fraction 2,
named rondonin, was puriﬁed to homogeneity.inimal inhibitory concentrations (MICs) of the synthetic peptides were determined
ions where (a) is the highest concentration tested at which the microorganisms are
hibitory concentration (mM)
Gomesin
ND 0.4 – 0.8a
ND 1.2 – 2.5b
ND NA
ND 0.4 – 0.8a
ND 0.2 – 0.9b
ND NA
ND NA
– 2.1 0.6 – 1.2b
– 33.5 0.15 – 0.3a
– 33.5 5.0 – 10.0b
– 16.5 12.5 – 25
– 16.5 5.0 – 10.0b
– 33.5 2.5 – 5.0b
– 16.5 0.3 – 0.6b
– 33.5 2.5 – 5.0b
concentration tested; NA, activity not available.
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The MIC of synthetic rondonin was tested against Gram-
negative bacterial strains, Gram-positive bacterial strains, fungal
strains and yeast strains. Synthetic rondonin showed activity
against all yeasts tested and one fungus. However, no activity
could be detected against Gram-positive and Gram-negative
bacteria and the fungus Aspergilus niger, Cladosporium sp.,Fig. 2. Puriﬁcation of rondonin from spider plasma by reverse phase HPLC. An
acidic extract obtained from A. rondoniae plasma was submitted to solid phase
extraction on Sep-Pak C18 cartridges. The fraction that eluted at 40% acetonitrile
was analysed on a semi-preparative Jupiter C18 column with a linear gradient from
2% to 60% acetonitrile in acidiﬁed water over 60 min (dotted line) at a ﬂow rate of
1.5 mL/min.
Fig. 3. MALDI-TOF spectrum of fraction 2 (rondonin). Analysis of fraction 2 by
mass spectrometry showed a single molecule with an m/z of 1237.776.
Fig. 4. Representative ‘‘de novo’’ sequencing of fraction 2 from A. rondoniae plasma
series. The peptide sequence following the b and y series orientation is shown on the top
positive ionisation mode on a Q-TOF MicroTM ﬁtted with an electrospray ion source.Penicilium expansum and B. bassiana strains tested in the range
of concentration investigated (above 67 mM). MICs are expressed
as the (a) and (b) interval of concentrations where (a) is the
highest concentration tested at which the microorganisms are
growing and (b) is the lowest concentration that causes 100%
growth inhibition. We compare our results with the synthetic
gomesin performed by Silva et al. [35] and Yamane [44]. As
shown in Table 1, rondonin could be a speciﬁc antifungal activity
against yeasts.
3.4. MALDI-TOF and LC/MS analysis
Analysis by mass spectrometry MALDI-TOF revealed a single
molecule with a mass of 1236.776 Da (Fig. 3). Following the
methodology of Budnik et al. [4], ‘‘de novo’’ sequencing (Fig. 4)
of this molecule revealed a sequence of 10 amino acids, III-
QYEGHKH (Fig. 5), that showed identity to the C-terminus
fragment of the subunit ‘‘d’’ of haemocyanin from the tarantula
Eurypelma californicum (Theraphosidae) [42]. Furthermore, when
compared to a database of partial genomes, rondonin showed
identity with the C-terminus fragment of subunit ‘‘d’’ and 90%
similarity to a fragment (ILIQYEGHKH) of subunit ‘‘f’’ of haemo-
cyanin from the spider A. gomesiana (http://www.compsysbio.
org/partigene/). Therefore, in the present study, we report the ﬁrst
isolation and characterisation of a fragment of haemocyanin with
antifungal activity from arachnids.
3.5. Microbicidal activity of rondonin
The microbicidal properties of rondonin were determined by
the Neubauer chamber and plate count method. When synthetic
rondonin was incubated with C. albicans at a concentration two
times higher than the respective MIC, no living yeast were detectedin a Q-TOF Micro TM (Micromass). The fragments shown correspond to the b and y
of the graph. Mass spectrometric ‘‘de novo’’ peptide sequencing was performed in
Fig. 5. Eurypelma californicum (Theraphosidae) haemocyanin subunits (a–g).
The peptide showed identity with the C-terminal fragment from subunit ‘‘d’’ [42].
Fig. 6. Growth inhibition of Candida albicans MDM8 by rondonin. Synthetic
rondonin (67 mM, solid line) or water (control, dotted line) was added to an
exponential phase culture of C. albicans. Aliquots were removed at various times,
and the number of blastoconidia were counted in a Newbauer chamber. To test
the viability of blastoconidia, 20 mL aliquots for each time point were incubated on
Luria Bertani agar plates for 48 h at 30 1C.
Fig. 7. Toxicity of rondonin with HRBCs. Synthetic rondonin was incubated with
human erythrocytes ranging from 0.2 to 134 mM for 3 h at 37 1C. The haemolysis
percentage was expressed in relation to 0% haemolysis with PBS and 100% lysis
control (0.1% triton X-100).
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the growth of Candida albicans MDM8 compared to the control.
3.6. Toxicity to human red blood cells
Haemolytic assays were used to assess the toxicity of peptides
towards HRBCs in vitro. Incubating HRBCs (w/v) with various
concentrations of rondonin for 3 h at 37 1C did not affect the OD
at 414 nm. Triton X-100 was used as a positive control and taken
as the 100% haemolysis value. PBS was used as a negative control
and taken as the 0% haemolysis value. These results demonstrate
that rondonin is not haemolytic (Fig. 7).4. Discussion
Considering the studies of the immune system of inverte-
brates, the knowledge of the mechanisms involved in the immune
response of arachnids is less studied than Limulus polyphemus
[18]. The life expectancy of many invertebrates is as long as the
lifespan of vertebrates, despite the continuous challenge of
pathogens. All multicellular animals are subject to frequent
microbial challenges and the attack of endo- and ectoparasites.
In addition to defences against predators, survival depends on the
presence of an efﬁcient immune system that can quickly remove
or inactivate pathogenic organisms. The immune system of the
tarantula spider is particularly interesting because, in addition tohaving a life expectancy of more than 20 years [9], tarantula
spiders are also phylogenetically very old with fossil records
dating from the Devonian period (400 million years ago) [32,31].
In this work, we puriﬁed six molecules with antimicrobial
activity that have never been before described from the plasma of
the tarantula spider A. rondoniae. Only one molecule, rondonin,
which was named in honour of the studied species, was isolated
and characterised. Rondonin, a peptide characterised with anti-
fungal activity that inhibits the growth of C. albicans MDM8 in ten
minutes and exhibited fungicidal activity, like a study previous
with some antifungal agents like amphotericin B, ﬂuconazole and
LY303366 showed that ﬂuconazole and LY303366 are fungistatic
and amphotericin B exhibited fungicidal activity with a reduction
in Z3 log10 compared to the starting inoculum [21]. Furthermore,
rondonin showed no haemolytic activity, had identity with the
C-terminal fragment of subunit ‘‘d’’ of haemocyanin from the
tarantula Eurypelma californicum and A. gomesiana and showed
90% similarity with a fragment of subunit ‘‘f’’ of A. gomesiana,
differing in only the second amino acid: ILIQYEGHKH. Lee et al.
[24] also found a fragment of haemocyanin, named astacidin 1, in
the plasma of the crayﬁsh Pacifastacus leniusculus, which consists
of 16 amino acids with the sequence FKVQNQHGQVVKIFHH-
COOH, has a molecular mass of 1945.2 Da, and possesses anti-
microbial activity.
Destoumieux-Garzon et al. [6] showed that the plasma of
shrimp contains an original class of strictly antifungal (poly)pep-
tides with molecular masses ranging from 2753.2 Da for a peptide
from Penaeus vannamei, which consists of 23 amino acids with the
sequence FEDLPNFGHIQVKVFNHGEHIHH, 7982.4 Da for a peptide
of 31 amino acids from P. stylirostris (VTDGDADSAVPNLHHEN-
TEYNHYGSHGVYPDK) and 8362.8 Da for a 32 amino acid peptide,
also from P. stylirostris (LVVAVTDGDADSAVPNLHENTEYN-
HYGSHGVY). The two peptides from P. stylirostris revealed perfect
homology with the C-terminus of the haemocyanin of Penaeus.
In this case, the authors speculated that the penaeid shrimp
can use haemocyanin, which is abundant and readily available in
the plasma, to produce C-terminal fragments that possess broad
antifungal activities within the ﬁrst hours of an infection. There-
fore, haemocyanin has a potential function in crustacean immu-
nity by serving as a substrate for the generation of antifungal
(poly)peptides that could contribute to microorganism elimina-
tion in plasma. It remains to be established whether the mechan-
ism leading to the partial cleavage of haemocyanin is part of the
shrimp immune reaction and how involved this process can be in
an immediate and systemic antimicrobial response in shrimp.
This result suggests that, as observed in crustaceans, the
cleavage of haemocyanin and the production of peptide frag-
ments with antimicrobial activity also occur in spiders as a ﬁrst
line of defence against infection. Several studies suggest that
haemocyanins are involved in the arthropod immune system. The
activity of the haemocyanin fragment discovered in this study
reinforces that idea.
The identiﬁcation and characterisation of new substances can
lead to the development of new drugs that kill resistant patho-
genic microorganisms. This peptide has activity against clinical
isolates that cause candidiasis, one of the opportunistic pathogens
responsible for nosocomial infections that colonise human muco-
sal surfaces [30]. Yeasts of the genus Candida are signiﬁcant due
to the high frequency at which they colonise and infect a human
host. Candida species are found in the gastrointestinal tract in
20–80% of the healthy adult population. In addition, approxi-
mately 20–30% of women have Candida colonies in their vaginas
[7]. The increase in the prevalence of yeast infections is likely due
to the AIDS epidemic, cancer chemotherapy, organ and bone-
narrow transplants and invasive hospital procedures [43,45]
because of the overuse of antifungal agents, such as ﬂuconazole
K.C.T. Riciluca et al. / Results in Immunology 2 (2012) 66–71 71[45]. Due to its small size, rondonin can be synthesised quickly
and can kill yeast in ten minutes. Furthermore, no toxicity
towards human erythrocytes was observed in this study. There-
fore, rondonin may represent a new strategy for developing drugs
that neutralise or inhibit pathogens.Acknowledgements
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